Skip to content
Directory

Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
1,137
currently held
Exits tracked
410
hand-checked
Sectors covered
1
across the portfolio
Countries covered
38
from every market
1,419 companies matching · Page 29 of 29
Umecrine Mood
Rosetta Capital IV
Sweden
Active
Sector
Biotech
InvestorRosetta Capital
Entry
2013
Hold
13yr
Univercells
AFB Fund II
Belgium
Active
Sector
Biotech
InvestorAdBio Partners
Entry
2022
Hold
4yr
Unshackled
CVX Ventures
Denmark
Active
Sector
Biotech
InvestorCVX Ventures
Entry
2025
Hold
1yr
Vascurie
Almi Invest (Regional funds)
Sweden
Active
Sector
Biotech
InvestorAlmi Invest
Entry
2026
Hold
0yr
Vesigen Therapeutics
Leaps by Bayer
United States
Active
Sector
Biotech
InvestorLeaps by Bayer
Entry
2020
Hold
6yr
Vesper Bio
Lundbeckfonden BioCapital
Denmark
Active
Sector
Biotech
InvestorLundbeckfonden BioCapital
Entry
2012
Hold
14yr
Vespina Life Sciences, Inc.
TVM Life Science Innovation
United States
Active
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2021
Hold
5yr
Vincere Biosciences
Oscar & Paul Venture Capital Fund I
United States
Active
Sector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2025
Hold
1yr
Vir
Mubadala Capital Other Investments
United States
Active
Sector
Biotech
InvestorMubadala Capital
Entry
–
Viroclinics Biosciences
Summit Partners Portfolio
Netherlands
Active
Sector
Biotech
InvestorSummit Partners
Entry
2023
Hold
3yr
Virovet
Health for Life Capital II
Belgium
Active
Sector
Biotech
InvestorSeventure Partners
Entry
2023
Hold
3yr
VoxIBio
Almi Invest (Regional funds)
Sweden
Active
Sector
Biotech
InvestorAlmi Invest
Entry
2025
Hold
1yr
Werewool
Sofinnova Capital X
United States
Active
Sector
Biotech
InvestorSofinnova Partners
Entry
2022
Hold
4yr
Windward Bio AG
Novo Holdings Venture Investments
Switzerland
Active
Sector
Biotech
InvestorNovo Holdings
Entry
2026
Hold
0yr
Xilis
Mubadala Capital Other Investments
United States
Active
Sector
Biotech
InvestorMubadala Capital
Entry
–
Xintela
Flerie Invest
Sweden
Active
Sector
Biotech
InvestorFlerie
Entry
2022
Hold
4yr
Yukin Therapeutics
AFB Seed-Fund
France
Active
Sector
Biotech
InvestorAdBio Partners
Entry
2019
Hold
7yr
Zafrens
BlueYard Capital Fund III
US
Active
Sector
Biotech
InvestorBlueYard Capital
Entry
2023
Hold
3yr
Zencore Biologics
Novo Holdings Bioindustrial Investments
United States
Active
Sector
Biotech
InvestorNovo Holdings
Entry
2021
Hold
5yr
Previous1…26272829Next